INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE

Clinical trials for INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE explained in plain language.

Never miss a new study

Get alerted when new INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE trials appear

Sign up with your email to follow new studies for INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists Re-Engineer Patient's own cells to hunt down leukemia

Disease control Ongoing

This early-stage study is testing a new type of cellular therapy for adults with acute myeloid leukemia or a related blood cancer that has come back or not responded to standard treatments. Doctors collect a patient's or donor's immune cells, genetically modify them in a lab to b…

Matched conditions: INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE

Get alerted when new INTERLEUKIN-3 RECEPTOR SUBUNIT ALPHA POSITIVE trials appear

Scientists Re-Engineer Patient's own cells to hunt down leukemia